

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 7.81837265 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 7.81837265 |
| 3 | endocrine pancreas development (GO:0031018) | 5.61004216 |
| 4 | COPII vesicle coating (GO:0048208) | 5.40069127 |
| 5 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.32810187 |
| 6 | peptide hormone processing (GO:0016486) | 5.19536526 |
| 7 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.14996865 |
| 8 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.08786522 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.01202392 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 4.97265619 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.80253483 |
| 12 | glandular epithelial cell differentiation (GO:0002067) | 4.64906471 |
| 13 | protein retention in ER lumen (GO:0006621) | 4.60927222 |
| 14 | positive regulation of insulin secretion (GO:0032024) | 4.48576287 |
| 15 | urinary tract smooth muscle contraction (GO:0014848) | 4.45251700 |
| 16 | detection of calcium ion (GO:0005513) | 4.44266254 |
| 17 | protein maturation by protein folding (GO:0022417) | 4.34190261 |
| 18 | signal peptide processing (GO:0006465) | 4.31442575 |
| 19 | insulin secretion (GO:0030073) | 4.24873826 |
| 20 | sarcomere organization (GO:0045214) | 4.23772224 |
| 21 | postsynaptic membrane organization (GO:0001941) | 4.22005939 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.18603956 |
| 23 | regulation of insulin secretion (GO:0050796) | 4.07650977 |
| 24 | response to inactivity (GO:0014854) | 4.05901437 |
| 25 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.99325330 |
| 26 | exocrine pancreas development (GO:0031017) | 3.96202200 |
| 27 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.89130722 |
| 28 | regulation of sarcomere organization (GO:0060297) | 3.84348027 |
| 29 | sequestering of metal ion (GO:0051238) | 3.73726006 |
| 30 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.71672845 |
| 31 | regulation of peptide hormone secretion (GO:0090276) | 3.70027918 |
| 32 | regulation of peptide secretion (GO:0002791) | 3.65083653 |
| 33 | positive regulation of peptide hormone secretion (GO:0090277) | 3.64519561 |
| 34 | nitric oxide mediated signal transduction (GO:0007263) | 3.59913044 |
| 35 | positive regulation of peptide secretion (GO:0002793) | 3.58422079 |
| 36 | vesicle coating (GO:0006901) | 3.56656079 |
| 37 | positive regulation of glycolytic process (GO:0045821) | 3.55209953 |
| 38 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.54579661 |
| 39 | retinal cone cell development (GO:0046549) | 3.51190385 |
| 40 | muscle filament sliding (GO:0030049) | 3.50299756 |
| 41 | actin-myosin filament sliding (GO:0033275) | 3.50299756 |
| 42 | regulation of cell communication by electrical coupling (GO:0010649) | 3.47956598 |
| 43 | negative regulation of insulin secretion (GO:0046676) | 3.47588529 |
| 44 | positive regulation of nuclease activity (GO:0032075) | 3.47356851 |
| 45 | myotube cell development (GO:0014904) | 3.46919480 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.46389426 |
| 47 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.44848736 |
| 48 | growth hormone secretion (GO:0030252) | 3.41971343 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 3.40348096 |
| 50 | regulation of skeletal muscle contraction (GO:0014819) | 3.38419382 |
| 51 | skeletal muscle adaptation (GO:0043501) | 3.35888938 |
| 52 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.33066280 |
| 53 | negative regulation of protein localization to cell surface (GO:2000009) | 3.32995246 |
| 54 | detection of light stimulus involved in visual perception (GO:0050908) | 3.32816221 |
| 55 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.32816221 |
| 56 | glandular epithelial cell development (GO:0002068) | 3.32250045 |
| 57 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.30837167 |
| 58 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.29703332 |
| 59 | striated muscle contraction (GO:0006941) | 3.29405462 |
| 60 | membrane depolarization during action potential (GO:0086010) | 3.28776320 |
| 61 | response to pheromone (GO:0019236) | 3.28273265 |
| 62 | myofibril assembly (GO:0030239) | 3.25694508 |
| 63 | regulation of hormone secretion (GO:0046883) | 3.23724287 |
| 64 | skeletal muscle fiber development (GO:0048741) | 3.22686578 |
| 65 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.21851586 |
| 66 | peptide hormone secretion (GO:0030072) | 3.20567756 |
| 67 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.18605672 |
| 68 | actin filament-based movement (GO:0030048) | 3.16864342 |
| 69 | presynaptic membrane assembly (GO:0097105) | 3.16470814 |
| 70 | regulation of nuclease activity (GO:0032069) | 3.15718723 |
| 71 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.14185931 |
| 72 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.13865075 |
| 73 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.13209331 |
| 74 | skeletal muscle tissue regeneration (GO:0043403) | 3.11585391 |
| 75 | pharyngeal system development (GO:0060037) | 3.10630610 |
| 76 | regulation of glucocorticoid secretion (GO:2000849) | 3.10072930 |
| 77 | peptide secretion (GO:0002790) | 3.10014168 |
| 78 | regulation of oxidative phosphorylation (GO:0002082) | 3.09646886 |
| 79 | actin-mediated cell contraction (GO:0070252) | 3.07738190 |
| 80 | dicarboxylic acid catabolic process (GO:0043649) | 3.07251086 |
| 81 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.06956828 |
| 82 | protein localization to Golgi apparatus (GO:0034067) | 3.06668000 |
| 83 | positive regulation of gastrulation (GO:2000543) | 3.06198875 |
| 84 | cardiac myofibril assembly (GO:0055003) | 3.06127853 |
| 85 | photoreceptor cell maintenance (GO:0045494) | 3.04426525 |
| 86 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.03069085 |
| 87 | ketone body metabolic process (GO:1902224) | 3.01707524 |
| 88 | cell communication by electrical coupling (GO:0010644) | 3.00991974 |
| 89 | neuronal action potential (GO:0019228) | 3.00139180 |
| 90 | GDP-mannose metabolic process (GO:0019673) | 2.99477914 |
| 91 | negative regulation of peptide hormone secretion (GO:0090278) | 2.98624419 |
| 92 | cellular response to unfolded protein (GO:0034620) | 2.97203710 |
| 93 | positive regulation of vesicle fusion (GO:0031340) | 2.97032303 |
| 94 | response to muscle activity (GO:0014850) | 2.95875285 |
| 95 | muscle fiber development (GO:0048747) | 2.95805780 |
| 96 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.94876554 |
| 97 | regulation of peptide transport (GO:0090087) | 2.94572784 |
| 98 | cellular response to glucagon stimulus (GO:0071377) | 2.93656223 |
| 99 | indolalkylamine metabolic process (GO:0006586) | 2.92868257 |
| 100 | skeletal muscle contraction (GO:0003009) | 2.92153342 |
| 101 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.91425193 |
| 102 | cellular response to topologically incorrect protein (GO:0035967) | 2.90144547 |
| 103 | ER overload response (GO:0006983) | 2.89056862 |
| 104 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.89042997 |
| 105 | epithelial cell fate commitment (GO:0072148) | 2.88561588 |
| 106 | positive regulation of hormone secretion (GO:0046887) | 2.88482564 |
| 107 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.87631097 |
| 108 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.86750727 |
| 109 | response to dietary excess (GO:0002021) | 2.86584998 |
| 110 | toxin metabolic process (GO:0009404) | 2.86340894 |
| 111 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.86133276 |
| 112 | negative regulation of peptide secretion (GO:0002792) | 2.86027942 |
| 113 | carbohydrate homeostasis (GO:0033500) | 2.84717301 |
| 114 | glucose homeostasis (GO:0042593) | 2.84717301 |
| 115 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.84222420 |
| 116 | ER-nucleus signaling pathway (GO:0006984) | 2.83223269 |
| 117 | synaptic transmission, cholinergic (GO:0007271) | 2.83213095 |
| 118 | primitive streak formation (GO:0090009) | 2.82508339 |
| 119 | positive regulation of cation channel activity (GO:2001259) | 2.81635173 |
| 120 | astrocyte differentiation (GO:0048708) | 2.80467752 |
| 121 | reflex (GO:0060004) | 2.80046453 |
| 122 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.78581468 |
| 123 | tricarboxylic acid metabolic process (GO:0072350) | 2.76642851 |
| 124 | establishment of protein localization to Golgi (GO:0072600) | 2.76528883 |
| 125 | regulation of energy homeostasis (GO:2000505) | 2.76332788 |
| 126 | striated muscle atrophy (GO:0014891) | 2.75306190 |
| 127 | regulation of glucokinase activity (GO:0033131) | 2.74714655 |
| 128 | regulation of hexokinase activity (GO:1903299) | 2.74714655 |
| 129 | neural tube formation (GO:0001841) | 2.74678698 |
| 130 | regulation of membrane repolarization (GO:0060306) | 2.74405010 |
| 131 | regulation of pigment cell differentiation (GO:0050932) | 2.72828267 |
| 132 | plasma membrane repair (GO:0001778) | 2.72720176 |
| 133 | type B pancreatic cell development (GO:0003323) | 2.72638894 |
| 134 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.72344023 |
| 135 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.72344023 |
| 136 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.72158672 |
| 137 | cornea development in camera-type eye (GO:0061303) | 2.71774586 |
| 138 | macroautophagy (GO:0016236) | 2.70614170 |
| 139 | auditory receptor cell stereocilium organization (GO:0060088) | 2.70423444 |
| 140 | lactate metabolic process (GO:0006089) | 2.70158499 |
| 141 | kynurenine metabolic process (GO:0070189) | 2.70092977 |
| 142 | response to caffeine (GO:0031000) | 2.70023572 |
| 143 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.69283417 |
| 144 | C4-dicarboxylate transport (GO:0015740) | 2.69086415 |
| 145 | regulation of striated muscle contraction (GO:0006942) | 2.69017222 |
| 146 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.68848729 |
| 147 | adenosine metabolic process (GO:0046085) | 2.68557659 |
| 148 | neuromuscular synaptic transmission (GO:0007274) | 2.68527331 |
| 149 | regulation of actin filament-based movement (GO:1903115) | 2.68328631 |
| 150 | tryptophan catabolic process (GO:0006569) | 2.67437347 |
| 151 | indole-containing compound catabolic process (GO:0042436) | 2.67437347 |
| 152 | indolalkylamine catabolic process (GO:0046218) | 2.67437347 |
| 153 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.66201754 |
| 154 | aspartate family amino acid catabolic process (GO:0009068) | 2.65224885 |
| 155 | behavioral response to nicotine (GO:0035095) | 2.64190029 |
| 156 | muscle contraction (GO:0006936) | 2.64056982 |
| 157 | behavioral response to ethanol (GO:0048149) | 2.63959274 |
| 158 | presynaptic membrane organization (GO:0097090) | 2.63348881 |
| 159 | positive regulation of developmental pigmentation (GO:0048087) | 2.61887805 |
| 160 | relaxation of cardiac muscle (GO:0055119) | 2.61574846 |
| 161 | actomyosin structure organization (GO:0031032) | 2.61128553 |
| 162 | regulation of cilium movement (GO:0003352) | 2.60396754 |
| 163 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.58864011 |
| 164 | cardiac muscle hypertrophy (GO:0003300) | 2.58098969 |
| 165 | striated muscle adaptation (GO:0014888) | 2.55989550 |
| 166 | DNA double-strand break processing (GO:0000729) | 2.53639585 |
| 167 | gamma-aminobutyric acid transport (GO:0015812) | 2.53240153 |
| 168 | tachykinin receptor signaling pathway (GO:0007217) | 2.52942683 |
| 169 | muscle system process (GO:0003012) | 2.52053725 |
| 170 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.51844776 |
| 171 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.51844776 |
| 172 | muscle atrophy (GO:0014889) | 2.50750113 |
| 173 | protein K11-linked deubiquitination (GO:0035871) | 2.48808307 |
| 174 | relaxation of muscle (GO:0090075) | 2.48725004 |
| 175 | calcium ion import (GO:0070509) | 2.48126500 |
| 176 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.47809362 |
| 177 | cellular response to sterol (GO:0036315) | 2.47510476 |
| 178 | interkinetic nuclear migration (GO:0022027) | 2.45812021 |
| 179 | striated muscle hypertrophy (GO:0014897) | 2.44115887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.40294479 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.93961490 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.85433625 |
| 4 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.77258850 |
| 5 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.63469995 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.53065366 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.28699789 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.07574076 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06249471 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03487128 |
| 11 | P300_19829295_ChIP-Seq_ESCs_Human | 1.99425886 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 1.99205628 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.95097599 |
| 14 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.90146120 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.88700535 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86373739 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.81429675 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.80550870 |
| 19 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.79790939 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78520948 |
| 21 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.78195700 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77629826 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71355386 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67097942 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.65613691 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64730840 |
| 27 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.64047599 |
| 28 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.63233785 |
| 29 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.62523001 |
| 30 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.62523001 |
| 31 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.61099159 |
| 32 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60105290 |
| 33 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.60105290 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.59831883 |
| 35 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.58895339 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58217099 |
| 37 | AR_25329375_ChIP-Seq_VCAP_Human | 1.57859599 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.56381282 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.55410120 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.52970940 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52833768 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52747354 |
| 43 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.51895025 |
| 44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.51895025 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51615839 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.51211977 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.50400611 |
| 48 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.49379212 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.48926797 |
| 50 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.47937749 |
| 51 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.47338157 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.45031305 |
| 53 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.44885226 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40393931 |
| 55 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.40133404 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.40133404 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40034812 |
| 58 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.39922734 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38596614 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37009587 |
| 61 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35928642 |
| 62 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35832742 |
| 63 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35485503 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33643252 |
| 65 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.33207542 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32490653 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31629637 |
| 68 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.31406835 |
| 69 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.30713213 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30215161 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29298237 |
| 72 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.28353537 |
| 73 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.27823395 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26882746 |
| 75 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25418451 |
| 76 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.25332945 |
| 77 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25194034 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25173934 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24755286 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22440852 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21800656 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21416617 |
| 83 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.21410427 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20002711 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19889150 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19231940 |
| 87 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.18997515 |
| 88 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18689433 |
| 89 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.18620828 |
| 90 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18371925 |
| 91 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17748927 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14881744 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13674872 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12806970 |
| 95 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.12202588 |
| 96 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10947179 |
| 97 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.10495522 |
| 98 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09140200 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09082008 |
| 100 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08825562 |
| 101 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08660303 |
| 102 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08602568 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08029548 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07730527 |
| 105 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.06970326 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06203444 |
| 107 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05463333 |
| 108 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05107124 |
| 109 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04061392 |
| 110 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03478674 |
| 111 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03059472 |
| 112 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01215951 |
| 113 | AR_19668381_ChIP-Seq_PC3_Human | 1.00939550 |
| 114 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00789836 |
| 115 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00638700 |
| 116 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99637840 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98060426 |
| 118 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97739365 |
| 119 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96701549 |
| 120 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96581122 |
| 121 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.96309465 |
| 122 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95780320 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95340537 |
| 124 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95198343 |
| 125 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95152541 |
| 126 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.94860860 |
| 127 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94856563 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94736383 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94736383 |
| 130 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93933749 |
| 131 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93545395 |
| 132 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.93132703 |
| 133 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.92817594 |
| 134 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92791758 |
| 135 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92249165 |
| 136 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92047338 |
| 137 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.91919585 |
| 138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91750758 |
| 139 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91337187 |
| 140 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91015449 |
| 141 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89383282 |
| 142 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89374845 |
| 143 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.89278039 |
| 144 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88247616 |
| 145 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86971205 |
| 146 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86902477 |
| 147 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85451698 |
| 148 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.85120372 |
| 149 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85024284 |
| 150 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84417788 |
| 151 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84147745 |
| 152 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82997276 |
| 153 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82390665 |
| 154 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.81773978 |
| 155 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.80847803 |
| 156 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.80832159 |
| 157 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80642615 |
| 158 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80034236 |
| 159 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.79849192 |
| 160 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79517339 |
| 161 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78895994 |
| 162 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78577232 |
| 163 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78452385 |
| 164 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.78317056 |
| 165 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.77498855 |
| 166 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.76271474 |
| 167 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.76077298 |
| 168 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.75862510 |
| 169 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.75840776 |
| 170 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.75840776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.48825081 |
| 2 | MP0000013_abnormal_adipose_tissue | 3.81240444 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.58365126 |
| 4 | MP0003283_abnormal_digestive_organ | 3.41481230 |
| 5 | MP0010386_abnormal_urinary_bladder | 3.37166310 |
| 6 | MP0002909_abnormal_adrenal_gland | 3.32381564 |
| 7 | MP0004043_abnormal_pH_regulation | 3.31140103 |
| 8 | MP0000749_muscle_degeneration | 3.00241471 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.93098541 |
| 10 | MP0003195_calcinosis | 2.92092305 |
| 11 | MP0002693_abnormal_pancreas_physiology | 2.89355680 |
| 12 | MP0001944_abnormal_pancreas_morphology | 2.84528856 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.79790364 |
| 14 | MP0000751_myopathy | 2.63942084 |
| 15 | MP0003646_muscle_fatigue | 2.63564966 |
| 16 | MP0006072_abnormal_retinal_apoptosis | 2.53988390 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.51776307 |
| 18 | MP0004036_abnormal_muscle_relaxation | 2.48151212 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.42790908 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 2.27454479 |
| 21 | MP0005220_abnormal_exocrine_pancreas | 2.26986317 |
| 22 | MP0004215_abnormal_myocardial_fiber | 2.26058933 |
| 23 | MP0000003_abnormal_adipose_tissue | 2.15498718 |
| 24 | MP0004233_abnormal_muscle_weight | 2.13982147 |
| 25 | MP0002269_muscular_atrophy | 2.12355072 |
| 26 | MP0000678_abnormal_parathyroid_gland | 2.08168445 |
| 27 | MP0002078_abnormal_glucose_homeostasis | 2.04452610 |
| 28 | MP0002736_abnormal_nociception_after | 2.03873748 |
| 29 | MP0001968_abnormal_touch/_nociception | 2.02576927 |
| 30 | MP0000372_irregular_coat_pigmentation | 1.98288183 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.96524602 |
| 32 | MP0006292_abnormal_olfactory_placode | 1.96444721 |
| 33 | MP0009046_muscle_twitch | 1.85359659 |
| 34 | MP0003122_maternal_imprinting | 1.85181635 |
| 35 | MP0002234_abnormal_pharynx_morphology | 1.81600755 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.78727944 |
| 37 | MP0000747_muscle_weakness | 1.68281339 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.64192439 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.60433736 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.59836755 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.57547182 |
| 42 | MP0002106_abnormal_muscle_physiology | 1.56466353 |
| 43 | MP0005620_abnormal_muscle_contractility | 1.55376051 |
| 44 | MP0002102_abnormal_ear_morphology | 1.53695811 |
| 45 | MP0003136_yellow_coat_color | 1.52818479 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.50347713 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.50309738 |
| 48 | MP0003880_abnormal_central_pattern | 1.49387327 |
| 49 | MP0004087_abnormal_muscle_fiber | 1.47938338 |
| 50 | MP0008877_abnormal_DNA_methylation | 1.45435332 |
| 51 | MP0002272_abnormal_nervous_system | 1.45280674 |
| 52 | MP0004270_analgesia | 1.43530028 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.42380288 |
| 54 | MP0004130_abnormal_muscle_cell | 1.41420620 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.40121737 |
| 56 | MP0009745_abnormal_behavioral_response | 1.35553370 |
| 57 | MP0004142_abnormal_muscle_tone | 1.34221179 |
| 58 | MP0005369_muscle_phenotype | 1.33964842 |
| 59 | MP0005670_abnormal_white_adipose | 1.33433405 |
| 60 | MP0005266_abnormal_metabolism | 1.33345052 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.32427781 |
| 62 | MP0002928_abnormal_bile_duct | 1.31957148 |
| 63 | MP0001486_abnormal_startle_reflex | 1.31210232 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.30819448 |
| 65 | MP0005375_adipose_tissue_phenotype | 1.29932493 |
| 66 | MP0005330_cardiomyopathy | 1.29275211 |
| 67 | MP0002972_abnormal_cardiac_muscle | 1.28865313 |
| 68 | MP0003879_abnormal_hair_cell | 1.26818226 |
| 69 | MP0004484_altered_response_of | 1.25247960 |
| 70 | MP0001485_abnormal_pinna_reflex | 1.25189448 |
| 71 | MP0001765_abnormal_ion_homeostasis | 1.25032151 |
| 72 | MP0008057_abnormal_DNA_replication | 1.24241919 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.22451063 |
| 74 | MP0004147_increased_porphyrin_level | 1.21252302 |
| 75 | MP0008775_abnormal_heart_ventricle | 1.20442966 |
| 76 | MP0002733_abnormal_thermal_nociception | 1.19541970 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.16666381 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.14582906 |
| 79 | MP0004085_abnormal_heartbeat | 1.13413422 |
| 80 | MP0005253_abnormal_eye_physiology | 1.12968959 |
| 81 | MP0003953_abnormal_hormone_level | 1.11724511 |
| 82 | MP0005423_abnormal_somatic_nervous | 1.09737804 |
| 83 | MP0001984_abnormal_olfaction | 1.09159244 |
| 84 | MP0001970_abnormal_pain_threshold | 1.08107125 |
| 85 | MP0002896_abnormal_bone_mineralization | 1.07984158 |
| 86 | MP0000569_abnormal_digit_pigmentation | 1.07429857 |
| 87 | MP0002822_catalepsy | 1.05803190 |
| 88 | MP0003045_fibrosis | 1.05580613 |
| 89 | MP0000230_abnormal_systemic_arterial | 1.04334063 |
| 90 | MP0000462_abnormal_digestive_system | 1.03256478 |
| 91 | MP0002067_abnormal_sensory_capabilities | 1.03193859 |
| 92 | MP0000750_abnormal_muscle_regeneration | 1.03081460 |
| 93 | MP0002064_seizures | 1.02593968 |
| 94 | MP0003959_abnormal_lean_body | 1.00073287 |
| 95 | MP0008872_abnormal_physiological_respon | 0.98844572 |
| 96 | MP0002090_abnormal_vision | 0.97871543 |
| 97 | MP0003635_abnormal_synaptic_transmissio | 0.97689650 |
| 98 | MP0005535_abnormal_body_temperature | 0.96803526 |
| 99 | MP0002971_abnormal_brown_adipose | 0.96752689 |
| 100 | MP0003787_abnormal_imprinting | 0.96056672 |
| 101 | MP0001756_abnormal_urination | 0.95462915 |
| 102 | MP0003890_abnormal_embryonic-extraembry | 0.93523323 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.92319271 |
| 104 | MP0000427_abnormal_hair_cycle | 0.90356092 |
| 105 | MP0003868_abnormal_feces_composition | 0.89946985 |
| 106 | MP0000613_abnormal_salivary_gland | 0.88766109 |
| 107 | MP0006036_abnormal_mitochondrial_physio | 0.88687141 |
| 108 | MP0004924_abnormal_behavior | 0.86465823 |
| 109 | MP0005386_behavior/neurological_phenoty | 0.86465823 |
| 110 | MP0003698_abnormal_male_reproductive | 0.86303122 |
| 111 | MP0000733_abnormal_muscle_development | 0.85716816 |
| 112 | MP0004510_myositis | 0.82238901 |
| 113 | MP0002572_abnormal_emotion/affect_behav | 0.79124419 |
| 114 | MP0003119_abnormal_digestive_system | 0.79033884 |
| 115 | MP0000631_abnormal_neuroendocrine_gland | 0.78847996 |
| 116 | MP0009697_abnormal_copulation | 0.77770193 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.77177377 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.77068604 |
| 119 | MP0005410_abnormal_fertilization | 0.77036453 |
| 120 | MP0000383_abnormal_hair_follicle | 0.76953478 |
| 121 | MP0002127_abnormal_cardiovascular_syste | 0.76755569 |
| 122 | MP0002557_abnormal_social/conspecific_i | 0.76739311 |
| 123 | MP0006276_abnormal_autonomic_nervous | 0.75517117 |
| 124 | MP0005187_abnormal_penis_morphology | 0.73951652 |
| 125 | MP0003633_abnormal_nervous_system | 0.72017723 |
| 126 | MP0008058_abnormal_DNA_repair | 0.70932569 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.70369368 |
| 128 | MP0010630_abnormal_cardiac_muscle | 0.70090755 |
| 129 | MP0001929_abnormal_gametogenesis | 0.69917818 |
| 130 | MP0005334_abnormal_fat_pad | 0.69178382 |
| 131 | MP0005365_abnormal_bile_salt | 0.69071550 |
| 132 | MP0005448_abnormal_energy_balance | 0.68565703 |
| 133 | MP0004885_abnormal_endolymph | 0.67379081 |
| 134 | MP0001270_distended_abdomen | 0.66267703 |
| 135 | MP0005452_abnormal_adipose_tissue | 0.64914208 |
| 136 | MP0005636_abnormal_mineral_homeostasis | 0.64671807 |
| 137 | MP0004264_abnormal_extraembryonic_tissu | 0.64486023 |
| 138 | MP0002734_abnormal_mechanical_nocicepti | 0.63472024 |
| 139 | MP0002184_abnormal_innervation | 0.63081681 |
| 140 | MP0002163_abnormal_gland_morphology | 0.62851981 |
| 141 | MP0002108_abnormal_muscle_morphology | 0.59731597 |
| 142 | MP0001661_extended_life_span | 0.59704740 |
| 143 | MP0002229_neurodegeneration | 0.59108524 |
| 144 | MP0003172_abnormal_lysosome_physiology | 0.57446954 |
| 145 | MP0005385_cardiovascular_system_phenoty | 0.56781858 |
| 146 | MP0001544_abnormal_cardiovascular_syste | 0.56781858 |
| 147 | MP0002970_abnormal_white_adipose | 0.56420984 |
| 148 | MP0001299_abnormal_eye_distance/ | 0.55069671 |
| 149 | MP0009672_abnormal_birth_weight | 0.54833213 |
| 150 | MP0002138_abnormal_hepatobiliary_system | 0.54775305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.51738665 |
| 2 | Hypoglycemic seizures (HP:0002173) | 6.62999979 |
| 3 | Hypoglycemic coma (HP:0001325) | 6.39119540 |
| 4 | Symptomatic seizures (HP:0011145) | 5.91547796 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.84978223 |
| 6 | Hyperglycemia (HP:0003074) | 5.33126597 |
| 7 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.83407869 |
| 8 | Ketoacidosis (HP:0001993) | 4.54418752 |
| 9 | Exercise-induced myalgia (HP:0003738) | 4.50569323 |
| 10 | Myoglobinuria (HP:0002913) | 4.09832932 |
| 11 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.98698596 |
| 12 | Large for gestational age (HP:0001520) | 3.88037093 |
| 13 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.83983969 |
| 14 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.83983969 |
| 15 | Late onset (HP:0003584) | 3.83105387 |
| 16 | Calf muscle hypertrophy (HP:0008981) | 3.76385629 |
| 17 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.74303583 |
| 18 | Absent phalangeal crease (HP:0006109) | 3.68059237 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.67511346 |
| 20 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.36761502 |
| 21 | Hypoplasia of the fovea (HP:0007750) | 3.36761502 |
| 22 | Sudden death (HP:0001699) | 3.27099567 |
| 23 | Hyperkalemia (HP:0002153) | 3.23020776 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 3.19994801 |
| 25 | Abnormal pancreas size (HP:0012094) | 3.16191306 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.15046539 |
| 27 | Exercise-induced muscle cramps (HP:0003710) | 3.14419594 |
| 28 | Prolonged QT interval (HP:0001657) | 3.12809729 |
| 29 | Fetal akinesia sequence (HP:0001989) | 3.10438772 |
| 30 | Abnormality of the fovea (HP:0000493) | 3.06217810 |
| 31 | Hyperventilation (HP:0002883) | 3.01505591 |
| 32 | Insulin resistance (HP:0000855) | 2.89966354 |
| 33 | Ketosis (HP:0001946) | 2.89849249 |
| 34 | Rimmed vacuoles (HP:0003805) | 2.88743415 |
| 35 | Muscle fiber inclusion bodies (HP:0100299) | 2.86520093 |
| 36 | Hypokalemia (HP:0002900) | 2.81759816 |
| 37 | Decreased circulating renin level (HP:0003351) | 2.79090346 |
| 38 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.77498458 |
| 39 | Areflexia of lower limbs (HP:0002522) | 2.74321235 |
| 40 | Retinal atrophy (HP:0001105) | 2.72967084 |
| 41 | Gaze-evoked nystagmus (HP:0000640) | 2.71285626 |
| 42 | Muscle fiber splitting (HP:0003555) | 2.67825009 |
| 43 | Abnormality of the calf musculature (HP:0001430) | 2.66377865 |
| 44 | Asymmetric septal hypertrophy (HP:0001670) | 2.64430314 |
| 45 | Malignant hyperthermia (HP:0002047) | 2.61601573 |
| 46 | Frequent falls (HP:0002359) | 2.61453758 |
| 47 | Round ear (HP:0100830) | 2.58715373 |
| 48 | Myopathic facies (HP:0002058) | 2.56567053 |
| 49 | Long clavicles (HP:0000890) | 2.56109438 |
| 50 | Syncope (HP:0001279) | 2.54922562 |
| 51 | Abnormality of potassium homeostasis (HP:0011042) | 2.54262049 |
| 52 | Gout (HP:0001997) | 2.51334552 |
| 53 | Palpitations (HP:0001962) | 2.49621982 |
| 54 | Bundle branch block (HP:0011710) | 2.48590099 |
| 55 | Ventricular tachycardia (HP:0004756) | 2.46489092 |
| 56 | Hemiparesis (HP:0001269) | 2.44790566 |
| 57 | Osteomalacia (HP:0002749) | 2.41695414 |
| 58 | Facial diplegia (HP:0001349) | 2.40912203 |
| 59 | Atrial fibrillation (HP:0005110) | 2.38612844 |
| 60 | Congenital stationary night blindness (HP:0007642) | 2.35373915 |
| 61 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35137701 |
| 62 | Nemaline bodies (HP:0003798) | 2.29617962 |
| 63 | Febrile seizures (HP:0002373) | 2.29435070 |
| 64 | Abnormality of the ischium (HP:0003174) | 2.28833229 |
| 65 | Pheochromocytoma (HP:0002666) | 2.27638459 |
| 66 | Pancreatic cysts (HP:0001737) | 2.27410318 |
| 67 | Clumsiness (HP:0002312) | 2.27156435 |
| 68 | Attenuation of retinal blood vessels (HP:0007843) | 2.26070564 |
| 69 | Abnormal EKG (HP:0003115) | 2.25099374 |
| 70 | Epileptiform EEG discharges (HP:0011182) | 2.24977432 |
| 71 | Agitation (HP:0000713) | 2.24762583 |
| 72 | Type 1 muscle fiber predominance (HP:0003803) | 2.24520615 |
| 73 | Hyporeflexia of lower limbs (HP:0002600) | 2.22426826 |
| 74 | Broad-based gait (HP:0002136) | 2.20744817 |
| 75 | Neck muscle weakness (HP:0000467) | 2.20557491 |
| 76 | Hypoplastic ischia (HP:0003175) | 2.18271196 |
| 77 | Absence seizures (HP:0002121) | 2.17601569 |
| 78 | Dialeptic seizures (HP:0011146) | 2.16291086 |
| 79 | EMG: myopathic abnormalities (HP:0003458) | 2.14217566 |
| 80 | Primary atrial arrhythmia (HP:0001692) | 2.13590100 |
| 81 | Thyroid-stimulating hormone excess (HP:0002925) | 2.11543466 |
| 82 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.11510107 |
| 83 | Subaortic stenosis (HP:0001682) | 2.11510107 |
| 84 | Fair hair (HP:0002286) | 2.10683574 |
| 85 | Right ventricular cardiomyopathy (HP:0011663) | 2.07852581 |
| 86 | Prominent metopic ridge (HP:0005487) | 2.07383700 |
| 87 | Abnormality of binocular vision (HP:0011514) | 2.06561729 |
| 88 | Diplopia (HP:0000651) | 2.06561729 |
| 89 | Abnormality of the renal cortex (HP:0011035) | 2.06009133 |
| 90 | Calcaneovalgus deformity (HP:0001848) | 2.05991902 |
| 91 | Ventricular fibrillation (HP:0001663) | 2.05133072 |
| 92 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.02817888 |
| 93 | Genetic anticipation (HP:0003743) | 2.02643599 |
| 94 | Pancreatic fibrosis (HP:0100732) | 2.02285382 |
| 95 | Nonprogressive disorder (HP:0003680) | 2.02111539 |
| 96 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.01812123 |
| 97 | Focal seizures (HP:0007359) | 2.00545134 |
| 98 | Type II lissencephaly (HP:0007260) | 1.99288863 |
| 99 | Supraventricular tachycardia (HP:0004755) | 1.98195861 |
| 100 | Absent speech (HP:0001344) | 1.98101619 |
| 101 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.97043886 |
| 102 | Type 2 muscle fiber atrophy (HP:0003554) | 1.96951124 |
| 103 | Medial flaring of the eyebrow (HP:0010747) | 1.96565146 |
| 104 | Cerebellar dysplasia (HP:0007033) | 1.96317181 |
| 105 | Weak cry (HP:0001612) | 1.95571343 |
| 106 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.95173126 |
| 107 | Distal arthrogryposis (HP:0005684) | 1.94813993 |
| 108 | Chronic hepatic failure (HP:0100626) | 1.93808494 |
| 109 | Fatigable weakness (HP:0003473) | 1.93165861 |
| 110 | Abnormality of the neuromuscular junction (HP:0003398) | 1.93165861 |
| 111 | Visual hallucinations (HP:0002367) | 1.92455186 |
| 112 | Dilated cardiomyopathy (HP:0001644) | 1.92440643 |
| 113 | Hyperphosphatemia (HP:0002905) | 1.92113894 |
| 114 | Neuroendocrine neoplasm (HP:0100634) | 1.92017023 |
| 115 | Supraventricular arrhythmia (HP:0005115) | 1.92009302 |
| 116 | Hypsarrhythmia (HP:0002521) | 1.91443113 |
| 117 | Generalized tonic-clonic seizures (HP:0002069) | 1.91362528 |
| 118 | True hermaphroditism (HP:0010459) | 1.91076216 |
| 119 | Difficulty running (HP:0009046) | 1.88544997 |
| 120 | Deformed tarsal bones (HP:0008119) | 1.87770182 |
| 121 | Myotonia (HP:0002486) | 1.86182090 |
| 122 | Neoplasm of the adrenal gland (HP:0100631) | 1.85610347 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84885397 |
| 124 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84885397 |
| 125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84885397 |
| 126 | Rhabdomyolysis (HP:0003201) | 1.84582765 |
| 127 | Limb hypertonia (HP:0002509) | 1.84243376 |
| 128 | Focal motor seizures (HP:0011153) | 1.84109423 |
| 129 | Progressive cerebellar ataxia (HP:0002073) | 1.84019987 |
| 130 | EMG: neuropathic changes (HP:0003445) | 1.83456107 |
| 131 | Mucopolysacchariduria (HP:0008155) | 1.83328010 |
| 132 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83328010 |
| 133 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.83154614 |
| 134 | Inability to walk (HP:0002540) | 1.82982260 |
| 135 | Renal cortical cysts (HP:0000803) | 1.82841785 |
| 136 | Difficulty climbing stairs (HP:0003551) | 1.81669992 |
| 137 | Hyperparathyroidism (HP:0000843) | 1.80695915 |
| 138 | Popliteal pterygium (HP:0009756) | 1.79695029 |
| 139 | Hepatoblastoma (HP:0002884) | 1.79631115 |
| 140 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79382072 |
| 141 | Central scotoma (HP:0000603) | 1.79015706 |
| 142 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78883391 |
| 143 | Abnormality of alanine metabolism (HP:0010916) | 1.78883391 |
| 144 | Hyperalaninemia (HP:0003348) | 1.78883391 |
| 145 | Dysostosis multiplex (HP:0000943) | 1.78787121 |
| 146 | Maternal diabetes (HP:0009800) | 1.78022949 |
| 147 | Abnormality of the intrinsic pathway (HP:0010989) | 1.77576746 |
| 148 | Protruding tongue (HP:0010808) | 1.77547648 |
| 149 | Abnormality of the metopic suture (HP:0005556) | 1.76374061 |
| 150 | Ulnar deviation of the wrist (HP:0003049) | 1.75158247 |
| 151 | Lipoatrophy (HP:0100578) | 1.74830548 |
| 152 | Hip contracture (HP:0003273) | 1.74166776 |
| 153 | Intestinal atresia (HP:0011100) | 1.73667505 |
| 154 | Progressive inability to walk (HP:0002505) | 1.73640247 |
| 155 | Left ventricular hypertrophy (HP:0001712) | 1.72835712 |
| 156 | Abnormality of renin-angiotensin system (HP:0000847) | 1.72158823 |
| 157 | Gait imbalance (HP:0002141) | 1.72123754 |
| 158 | Muscle stiffness (HP:0003552) | 1.71184529 |
| 159 | Generalized muscle weakness (HP:0003324) | 1.68577859 |
| 160 | Nephronophthisis (HP:0000090) | 1.68561688 |
| 161 | Methylmalonic aciduria (HP:0012120) | 1.68541009 |
| 162 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.67574049 |
| 163 | Proximal amyotrophy (HP:0007126) | 1.66349805 |
| 164 | Atonic seizures (HP:0010819) | 1.65968207 |
| 165 | Polydipsia (HP:0001959) | 1.64731981 |
| 166 | Abnormal drinking behavior (HP:0030082) | 1.64731981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 7.94546614 |
| 2 | MAPK15 | 5.22459140 |
| 3 | WNK3 | 3.93153805 |
| 4 | PASK | 3.71692704 |
| 5 | PIK3CG | 2.91410112 |
| 6 | OBSCN | 2.70315188 |
| 7 | PRKD3 | 2.69557632 |
| 8 | PBK | 2.54618409 |
| 9 | HIPK2 | 2.45543900 |
| 10 | PHKG1 | 2.38129517 |
| 11 | PHKG2 | 2.38129517 |
| 12 | BMPR1B | 2.38040801 |
| 13 | ACVR1B | 2.19727432 |
| 14 | STK38L | 2.11984489 |
| 15 | MAP4K2 | 2.09132458 |
| 16 | ADRBK2 | 1.98941497 |
| 17 | FLT3 | 1.79134281 |
| 18 | MAPK13 | 1.77071213 |
| 19 | WNK4 | 1.76602405 |
| 20 | NME1 | 1.68287308 |
| 21 | TTN | 1.66841325 |
| 22 | PAK3 | 1.51613212 |
| 23 | CASK | 1.50589628 |
| 24 | EPHA3 | 1.48387666 |
| 25 | PINK1 | 1.43947633 |
| 26 | IRAK1 | 1.43881341 |
| 27 | IRAK3 | 1.42751382 |
| 28 | PDK2 | 1.40759027 |
| 29 | MKNK2 | 1.40029870 |
| 30 | GRK1 | 1.37820893 |
| 31 | ERN1 | 1.31897964 |
| 32 | CCNB1 | 1.22323517 |
| 33 | FER | 1.21926962 |
| 34 | UHMK1 | 1.19341804 |
| 35 | ZAK | 1.16085953 |
| 36 | BCKDK | 1.15401508 |
| 37 | MAP3K1 | 1.12407809 |
| 38 | MAP3K9 | 1.11260572 |
| 39 | MUSK | 1.06672156 |
| 40 | DYRK1B | 1.06023080 |
| 41 | PKN1 | 1.03918775 |
| 42 | CAMK2D | 1.02731612 |
| 43 | CDC42BPA | 1.01519431 |
| 44 | PNCK | 0.99211648 |
| 45 | PLK2 | 0.98683737 |
| 46 | PTK2B | 0.97963952 |
| 47 | PRKD2 | 0.96440227 |
| 48 | NEK1 | 0.95236586 |
| 49 | TAOK3 | 0.94652517 |
| 50 | AKT3 | 0.92548700 |
| 51 | MAPK12 | 0.91935282 |
| 52 | FGFR4 | 0.90226815 |
| 53 | STK3 | 0.90028294 |
| 54 | NTRK1 | 0.89351354 |
| 55 | PRKAA1 | 0.88862117 |
| 56 | IRAK2 | 0.87532749 |
| 57 | ADRBK1 | 0.86121600 |
| 58 | PAK6 | 0.85127517 |
| 59 | MAP2K7 | 0.83987719 |
| 60 | PDGFRA | 0.83601617 |
| 61 | PTK2 | 0.82640898 |
| 62 | SGK2 | 0.81661390 |
| 63 | MAP3K2 | 0.81057629 |
| 64 | VRK1 | 0.80217961 |
| 65 | DMPK | 0.78644077 |
| 66 | TNIK | 0.76573601 |
| 67 | PRKCH | 0.74416213 |
| 68 | CAMKK2 | 0.73440180 |
| 69 | SIK3 | 0.72887036 |
| 70 | SIK1 | 0.71723926 |
| 71 | BRSK2 | 0.71287715 |
| 72 | PLK4 | 0.69318250 |
| 73 | PRKCE | 0.68488873 |
| 74 | PTK6 | 0.68256713 |
| 75 | STK38 | 0.67623318 |
| 76 | FRK | 0.66132436 |
| 77 | OXSR1 | 0.64963642 |
| 78 | TEC | 0.63813541 |
| 79 | TRIB3 | 0.63290948 |
| 80 | PRKG1 | 0.63219506 |
| 81 | PRKCG | 0.62366233 |
| 82 | ERBB3 | 0.59363722 |
| 83 | TNK2 | 0.58048834 |
| 84 | NUAK1 | 0.58005496 |
| 85 | STK39 | 0.57735046 |
| 86 | CSNK1G1 | 0.56252070 |
| 87 | TRPM7 | 0.55697400 |
| 88 | RPS6KB1 | 0.55516668 |
| 89 | NTRK3 | 0.53892594 |
| 90 | CAMK1G | 0.51014597 |
| 91 | CAMK4 | 0.50308426 |
| 92 | WNK1 | 0.49681690 |
| 93 | STK16 | 0.49249104 |
| 94 | MAP2K4 | 0.47543020 |
| 95 | MAPK11 | 0.46346608 |
| 96 | TLK1 | 0.46170315 |
| 97 | PRKD1 | 0.46040793 |
| 98 | PRKAA2 | 0.45788688 |
| 99 | MARK2 | 0.45087441 |
| 100 | PIK3CA | 0.44404382 |
| 101 | RPS6KA5 | 0.43353348 |
| 102 | CSNK1D | 0.43347970 |
| 103 | EPHB1 | 0.42919153 |
| 104 | NLK | 0.42907522 |
| 105 | NTRK2 | 0.42657659 |
| 106 | ITK | 0.42126282 |
| 107 | MAP3K7 | 0.40815695 |
| 108 | SCYL2 | 0.40749126 |
| 109 | PDK3 | 0.40659578 |
| 110 | PDK4 | 0.40659578 |
| 111 | DAPK2 | 0.38938485 |
| 112 | CDK3 | 0.38637543 |
| 113 | PRKACB | 0.38460580 |
| 114 | KSR2 | 0.38383798 |
| 115 | TIE1 | 0.38327780 |
| 116 | CAMK2G | 0.37442649 |
| 117 | MKNK1 | 0.36522128 |
| 118 | TGFBR1 | 0.36509038 |
| 119 | SGK494 | 0.36121457 |
| 120 | SGK223 | 0.36121457 |
| 121 | CSNK1G2 | 0.34773849 |
| 122 | RET | 0.33926530 |
| 123 | LMTK2 | 0.33852539 |
| 124 | PRKACA | 0.33733335 |
| 125 | DYRK1A | 0.32637670 |
| 126 | SGK3 | 0.32483777 |
| 127 | ROCK1 | 0.32184615 |
| 128 | MARK3 | 0.31404285 |
| 129 | BRD4 | 0.31292225 |
| 130 | MET | 0.30916350 |
| 131 | EIF2AK3 | 0.30688914 |
| 132 | CSNK1G3 | 0.30187999 |
| 133 | RIPK1 | 0.29501263 |
| 134 | LATS1 | 0.29472881 |
| 135 | CSNK1A1L | 0.29179980 |
| 136 | BRAF | 0.28606482 |
| 137 | STK24 | 0.26159594 |
| 138 | ATM | 0.25947570 |
| 139 | MARK1 | 0.25901668 |
| 140 | CAMK1D | 0.25856454 |
| 141 | GSK3B | 0.25779539 |
| 142 | CAMK2A | 0.25691294 |
| 143 | PRKACG | 0.25679659 |
| 144 | MAP2K1 | 0.25514872 |
| 145 | CSNK1A1 | 0.25445080 |
| 146 | DYRK3 | 0.25056028 |
| 147 | SGK1 | 0.24842093 |
| 148 | CDC7 | 0.24405839 |
| 149 | MTOR | 0.23858936 |
| 150 | PRKCB | 0.23677871 |
| 151 | MAP3K5 | 0.23414004 |
| 152 | CAMK2B | 0.21073048 |
| 153 | PRKG2 | 0.20189251 |
| 154 | MAP2K2 | 0.19421592 |
| 155 | CAMK1 | 0.18975243 |
| 156 | JAK2 | 0.18574971 |
| 157 | PRKCA | 0.18272221 |
| 158 | MAP3K4 | 0.17668897 |
| 159 | MAPKAPK3 | 0.16752429 |
| 160 | CSK | 0.15933044 |
| 161 | RPS6KA3 | 0.15329464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 8.21265083 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.27655573 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 3.41959120 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.44314609 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.41772488 |
| 6 | Circadian rhythm_Homo sapiens_hsa04710 | 2.41695102 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.36143729 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.35465394 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.33449197 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.31356621 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29911254 |
| 12 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.19133429 |
| 13 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.15988208 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.99318424 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.88625996 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.74683738 |
| 17 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.68462648 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.56689328 |
| 19 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.54881589 |
| 20 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.54734379 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.52158865 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.51472335 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.45251370 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41752223 |
| 25 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.36998226 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30697919 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30063294 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.27410603 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.26129093 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.25107928 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.23638237 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.21920404 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20067506 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17776334 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.17536417 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16501243 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15406761 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15206069 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13273851 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12290680 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10804582 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10429388 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 1.07508060 |
| 44 | Morphine addiction_Homo sapiens_hsa05032 | 1.04265970 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.03959645 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02896108 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.02820306 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.00051207 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99663557 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99158816 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.98206331 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98022099 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97583889 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96361422 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.96159058 |
| 56 | Long-term depression_Homo sapiens_hsa04730 | 0.96035672 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95858480 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95587523 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 0.94589757 |
| 60 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.92874227 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91828493 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.91698509 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90424711 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90405725 |
| 65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89462493 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89192221 |
| 67 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89098067 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84175536 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84153440 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83823478 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82518566 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82254117 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80145165 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79724314 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79230892 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79106183 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79007673 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78367567 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75188414 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74790041 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74747511 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74354029 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71402600 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71373966 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69825004 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69605055 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68345029 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68004490 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.67820889 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.66405248 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.64233960 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62737975 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62364503 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.61485287 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60982837 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.60517218 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60184732 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60074978 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59667942 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57132190 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55446944 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54496874 |
| 103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53906768 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52690584 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50072973 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49397205 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49285361 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49023479 |
| 109 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.48919914 |
| 110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48887115 |
| 111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48584138 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48070898 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47917981 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47458002 |
| 115 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47272168 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46891725 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.46406216 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45551931 |
| 119 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44744039 |
| 120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44206812 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44199812 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42148007 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41078940 |
| 124 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38705151 |
| 125 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38090634 |
| 126 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37903938 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.37529653 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37389786 |
| 129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35644090 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34894328 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34678384 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34188433 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.34111040 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33822521 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.33582612 |
| 136 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33236910 |
| 137 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33095991 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32458440 |
| 139 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31749502 |
| 140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31300696 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28887145 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28018821 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27878734 |
| 144 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26336837 |

